Skip to main content

Pleural Disease: advances in pathology, diagnosis and therapeutic approach

Edited by:
Federico Mei, MD, Polytechnic University of Marche, Italy 
Eihab O Bedawi, PhD, Sheffield Teaching Hospitals and the University of Sheffield, United Kingdom 
 

Submission Status: Closed


This collection is no longer accepting submissions.


Respiratory Research is calling for submissions to our Collection on Pleural Disease: advances in pathology, diagnosis and therapeutic approach.

Image credit: Respiratory Unit of Dr. Federico Mei.




 

New Content ItemThis collection supports and amplifies research related to SDG 3: Good health and well-being

  1. Malignant pleural effusion (MPE) is a severe complication in lung cancer, characterized by an immunosuppressive tumor microenvironment (TME) and limited therapeutic options. This study investigates the role of...

    Authors: Qinpei Cheng, Xueying Zuo, Zimu Wang, Wanjun Lu, Yuxin Jiang, Jiaxin Liu, Xinying Li, Qiuli Xu, Suhua Zhu, Xin Liu, Yong Song, Ping Zhan and Tangfeng Lv
    Citation: Respiratory Research 2025 26:180
  2. Surgery is one of the preferred primary treatments for primary spontaneous pneumothorax (PSP); however, postoperative recurrent pneumothorax (PORP), defined as recurrence on the same side, occurs in 3–13% of c...

    Authors: Yu-Wei Liu, Chieh-Ni Kao, Chi-Chang Ho, Shah-Hwa Chou, Pau-Chung Chen and Shu-Hung Huang
    Citation: Respiratory Research 2025 26:176
  3. Classification of the etiologies of pleural effusion is a critical challenge in clinical practice. Traditional diagnostic methods rely on a simple cut-off method based on the laboratory tests. However, machine...

    Authors: Qing-Yu Chen, Shu-Min Yin, Ming-Ming Shao, Feng-Shuang Yi and Huan-Zhong Shi
    Citation: Respiratory Research 2025 26:170
  4. A significant proportion of patients with pneumothorax who do not tolerate surgery develop intractable pneumothorax after prolonged failure of conservative treatment. This significantly lengthens the duration ...

    Authors: Rui Xu, Kaige Wang, Jingyu Shi, Panwen Tian and Dan Liu
    Citation: Respiratory Research 2025 26:162
  5. Pleural infection is a commonly encountered respiratory disease but in > 40% the underlying microbiologic etiology is unknown. This feasibility study aims to investigate whether pleural fluid agitation prior t...

    Authors: Ahmed Sadaka, Reda Said, Heba Ashmawy, Hadir Okasha and Heba Gharraf
    Citation: Respiratory Research 2025 26:154
  6. In most cases, patients with pleural effusion require a pleural biopsy to confirm the diagnosis, due to the low diagnostic sensitivity of thoracentesis. Among the different biopsy modalities, real time compute...

    Authors: Rui Xu, Ling Zuo, Chiyong Yang, Li Jiang, Ying Liu, Ping Fan, Kaige Wang and Dan Liu
    Citation: Respiratory Research 2025 26:153
  7. Mesothelioma is a rare cancer that originates from the pleura and peritoneum, with its incidence increasing due to asbestos exposure. Patients are frequently diagnosed at advanced stages, resulting in poor sur...

    Authors: Jinsong Li, Xingmeng Wang, Yaru Lin, Zhengliang Li and Wei Xiong
    Citation: Respiratory Research 2025 26:140
  8. Bronchopleural fistulas (BPFs) are severe medical condition with high mortality. When the conventional surgical therapy failed, endobronchial intervention could function as the supplementary option. Several st...

    Authors: Zhibing Luo, Yanghong Zheng, Guo Ye, Yuhua Ma, Tingting Lin, Chen Chen, Dongmei Liu, Qiang Li and Na Wang
    Citation: Respiratory Research 2025 26:55
  9. Despite its heterogeneity, there is currently limited data in pleural infection phenotyping. Using pleural fluid characteristics, pleural infection can be classified into microbiological-positive pleural infec...

    Authors: Charles Wong, Hon Cheung Fan, Najib M. Rahman, Jeffrey Chi Chung Wong, Hei Shun Cheng, Pui Hing Chiu, Chun Wai Tong, Flora Pui Ling Miu and Loretta Yin Chun Yam
    Citation: Respiratory Research 2025 26:53
  10. Tuberculous pleural effusion (TPE) is a challenging extrapulmonary manifestation of tuberculosis, with traditional diagnostic methods often involving invasive surgery and being time-consuming. While various ma...

    Authors: Chaoling Wu, Wanyi Liu, Pengfei Mei, Yunyun Liu, Jian Cai, Lu Liu, Juan Wang, Xuefeng Ling, Mingxue Wang, Yuanyuan Cheng, Manbi He, Qin He, Qi He, Xiaoliang Yuan and Jianlin Tong
    Citation: Respiratory Research 2025 26:52
  11. Cobalt (Co) is a metal which is widely used in the industrial production. The previous studies found the toxic effects of environmental Co exposure on multiple organs. However, the correlation of blood Co conc...

    Authors: Fei Tang, Hong-Yan Liu, Qi-Yuan He, Ying Liu, Li-Ping Lv, Jun Fei and Lin Fu
    Citation: Respiratory Research 2024 25:324

About the Collection

Respiratory Research is calling for submissions to our Collection on Pleural Disease: advances in pathology, diagnosis and therapeutic approach. 

Due to the ever growing evidence base into the mechanisms, pathogenesis and management of the myriad conditions affecting the pleural space, as well as the growth of highly specialist physician-led interventions, pleural disease is now considered a distinct and important subspecialty of respiratory medicine.

The burden of pleural disease is considerable, with pleural effusions alone estimated to affect over million people per year worldwide. The range of pleural disease is broad, including malignant and benign conditions, curative or palliative and acute or chronic, presenting as entities in themselves or as part of a wide-ranging number of other medical and surgical conditions. Pleural disease may therefore present to respiratory physicians or to many other healthcare professionals, including surgery, general internal medicine, oncology, infectious diseases and oncology hence the crucial requirement for interspecialty and multidisciplinary involvement.  Interventions such as thoracoscopy, image-guided pleural biopsy and indwelling pleural catheters play a key role in pleural specialist practice, with thoracic ultrasound being the true revolutionary tool in the pleural physician’s arsenal.

To coincide with the above, over the past decade there has been a surge in the number of major studies, many of them randomized controlled trials with patient-centered outcomes, focusing on conditions such as pneumothorax, malignant pleural effusion, mesothelioma and pleural infection. Their results have in many respects been practice changing, and provided a range of new treatment options to be offered to patients with pleural conditions. This wave of robustly designed, multicenter studies will hopefully continue over the coming years.

Despite this substantial amount of high quality data, there remain significant gaps in the literature to be addressed, such as those relating to the phenotyping and optimal treatment of pleural infection, early diagnosis of mesothelioma, the optimal palliative strategy in malignant pleural effusion as well as the pathophysiology and mechanisms underpinning the development of pleural conditions.

This collection will welcome original articles or reviews on the clinical and pre-clinical diagnosis and management of pleural diseases and we look forward to your important contributions.

Submission Guidelines

Back to top

This Collection welcomes submission of original articles or reviews. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. 

Articles for this Collection should be submitted via our submission system, Snapp. Please, select the appropriate Collection title “Pleural Disease: advances in pathology, diagnosis and therapeutic approach" under the “Details” tab during the submission stage.

Articles will undergo the journal’s standard peer-review process and are subject to all the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer-review process. The peer-review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.